TMBR insider filings

Timber Pharmaceuticals, Inc. — 40 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-08-22. Screen TMBR transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for TMBR between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Timber Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2023-08-224Koconis John — CEO & ChairmanGrant/award (A): 70,385 @ $0EDGAR
2023-08-224Mendelsohn Alan — EVP & CMOGrant/award (A): 35,193 @ $0EDGAR
2023-08-224Lucchese Joseph — EVP & CFOGrant/award (A): 35,193 @ $0EDGAR
2023-04-184Koconis John — CEO & ChairmanGrant/award (A): 45,010 (derivative) @ $0EDGAR
2023-04-184Gaal Lubor — DirectorGrant/award (A): 4,100 @ $0 · Grant/award (A): 4,100 (derivative) @ $0EDGAR
2023-04-184Mendelsohn Alan — EVP & CMOGrant/award (A): 22,505 (derivative) @ $0EDGAR
2023-04-184Pirozzi Gianluca — DirectorGrant/award (A): 4,100 @ $0 · Grant/award (A): 4,100 (derivative) @ $0EDGAR
2023-04-184Sitar Edward J — DirectorGrant/award (A): 5,327 @ $0 · Grant/award (A): 5,327 (derivative) @ $0EDGAR
2023-04-184Lucchese Joseph — EVP & CFOGrant/award (A): 22,505 (derivative) @ $0EDGAR
2023-04-184Cohen David E — DirectorGrant/award (A): 4,100 @ $0 · Grant/award (A): 4,100 (derivative) @ $0EDGAR
2022-12-164Sitar Edward J — DirectorGrant/award (A): 2,500 @ $1.63EDGAR
2022-04-194Mendelsohn Alan — Chief Medical OfficerGrant/award (A): 300,000 (derivative) @ $0EDGAR
2022-04-194Lucchese Joseph — CFO,EVP,Secretary&TreasurerGrant/award (A): 300,000 (derivative) @ $0EDGAR
2022-04-194Koconis John — CEO & Chairman of the Board, DirectorGrant/award (A): 600,000 (derivative) @ $0EDGAR
2022-04-194Sitar Edward J — DirectorGrant/award (A): 150,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR
2022-04-194Pirozzi Gianluca — DirectorGrant/award (A): 100,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2022-04-194Gaal Lubor — DirectorGrant/award (A): 100,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2022-04-194Cohen David E — DirectorGrant/award (A): 100,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2022-04-154Rome Zachary — DirectorOption exercise (M): 79,326 @ $0.01 · Tax withholding (F): 19,630 @ $0.28 · Disposition to issuer (D): 52,884 (derivative) @ $0 · Option exercise (M): 79,326 (derivative) @ $0EDGAR
2021-12-164Koconis John — CEO & President, DirectorPurchase (P): 20,000 @ $0.38EDGAR
2021-11-244Mendelsohn Alan — Chief Medical OfficerPurchase (P): 10,000 @ $0.47EDGAR
2021-11-244Sitar Edward J — DirectorPurchase (P): 15,000 @ $0.46EDGAR
2021-09-294Lucchese Joseph — CFO, Executive VP & TreasurerGrant/award (A): 361,163 (derivative) @ $0EDGAR
2021-09-164Rome Zachary — COO, Executive VP & Secretary, DirectorGrant/award (A): 561,000 (derivative) @ $0EDGAR
2021-09-164Koconis John — CEO & President, DirectorGrant/award (A): 890,000 (derivative) @ $0EDGAR
2021-09-024TardiMed Sciences LLC — 10% ownerSale (S): 225,000 @ $0.94EDGAR
2021-09-014TardiMed Sciences LLC — 10% ownerSale (S): 100,000 @ $0.93 · Sale (S): 150,000 @ $0.91 · Sale (S): 150,500 @ $0.92EDGAR
2021-08-264TardiMed Sciences LLC — 10% ownerSale (S): 100,000 @ $0.93 · Sale (S): 100,000 @ $0.91 · Sale (S): 100,000 @ $0.92EDGAR
2021-08-204TardiMed Sciences LLC — 10% ownerSale (S): 75,000 @ $1.00 · Sale (S): 50,000 @ $0.95 · Sale (S): 50,000 @ $0.91EDGAR
2021-07-064Sitar Edward J — DirectorGrant/award (A): 47,623 (derivative) @ $0EDGAR
2021-07-064Pirozzi Gianluca — DirectorGrant/award (A): 47,623 (derivative) @ $0EDGAR
2021-07-064Mendelsohn Alan — Chief Medical OfficerGrant/award (A): 347,991 (derivative) @ $0EDGAR
2021-07-064Gaal Lubor — DirectorGrant/award (A): 71,893 (derivative) @ $0EDGAR
2021-07-064Cohen David E — DirectorGrant/award (A): 71,893 (derivative) @ $0EDGAR
2021-06-154TardiMed Sciences LLC — 10% ownerSale (S): 146,465 @ $1.27 · Sale (S): 28,450 @ $1.26EDGAR
2021-06-104TardiMed Sciences LLC — 10% ownerSale (S): 305,540 @ $1.29 · Sale (S): 96,481 @ $1.27 · Sale (S): 185,229 @ $1.26EDGAR
2021-06-024TardiMed Sciences LLC — 10% ownerSale (S): 47,736 @ $1.27 · Sale (S): 8,670 @ $1.26 · Sale (S): 9,879 @ $1.26EDGAR
2021-05-134Mendelsohn Alan — Chief Medical OfficerPurchase (P): 1,988 @ $2.17EDGAR
2020-09-164TardiMed Sciences LLC — 10% ownerSale (S): 455 @ $1.03 · Sale (S): 87,060 @ $1.03 · Sale (S): 100,694 @ $1.03EDGAR
2020-09-144TardiMed Sciences LLC — 10% ownerSale (S): 32,943 @ $1.04 · Sale (S): 7,483 @ $1.03EDGAR

Recent 8-K events — Timber Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-05-098-K/A1.03 — Bankruptcy or Receivership
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-05-098-K1.03 — Bankruptcy or Receivership
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-04-268-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-03-268-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-02-228-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-268-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-238-K1.01 — Entry into a Material Definitive Agreement
1.03 — Bankruptcy or Receivership
2.01 — Completion of Acquisition or Disposition of Assets
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
EDGAR
2023-12-228-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-288-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-178-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TMBR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs